focus -WSS

focus

author：hotspot 2025-08-24 10:13:53 - browse：3354

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Key House panel plots a new health care package

WSS

FDA approves RSV monoclonal antibody for infants, toddlers

FDA approves RSV monoclonal antibody for infants, toddlers

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

10 states plan to sue EPA over standards for residential wood

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Biden tests positive for Covid

focus

focus

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Moonlake's readout produced a cash windfall. Risks remain

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Affirmative action in medical school literally saved lives

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

In Memoriam: Notable people who died in 2023

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Apple is now the first public company to be valued at $3 trillion

Biden tests positive for Covid

entertainment

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

In early work, researchers turn to CRISPR to treat Alzheimer's

In early work, researchers turn to CRISPR to treat Alzheimer's

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Russians and Belarusians back at Wimbledon as war in Ukraine continues

hotspot

leisure time

explore

focus